Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies
Clinical trial NCT06801002 · RECRUITING
Trial details
- NCT number
- NCT06801002
- Sponsor
- Jabez Bioscience, Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-17
- Primary completion
- 2027-02-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.